Oregon Proposes Doubling Fees for Legal Psilocybin Program

Psiconáutica Editorial Team · July 21, 2026

In 2023, Oregon became the first U.S. state to launch a legal program for supervised psilocybin sessions for adults, without the need for a medical diagnosis. Three years later, the Oregon Health Authority (OHA)—the agency managing the program—has initiated a regulatory review process that proposes the largest fee increase since the program’s inception, a move the industry describes as a tipping point for its economic viability.

What the OHA is proposing

According to documentation from the Rules Advisory Committee, which met between July 6 and July 9, the annual license fee for service centers and psilocybin manufacturers would increase from $10,000 to $20,000 starting in January 2027. The 50% discount currently available to non-profits, veterans, and low-income individuals—which brings the cost to $5,000—would be eliminated, bringing those fees in line with the full rate. The facilitator license fee (for the individual accompanying the sessions) would rise from $2,000 to $4,000 per year, and the associated work permit would increase from $25 to $200. Testing laboratories would also see their fees double, though with a longer lead time: January 2029. Approximately 30% of current licenses utilize some form of discount, all of which would be removed.

A program funded solely by fees, without public money

The OHA justifies the increase by noting that Oregon’s psilocybin program receives no funding from the state’s general budget; it is sustained entirely by license fees. According to the agency, revenue has not kept pace with rising operating costs. Of the 39 centers that have held a license, about half have allowed them to expire or have returned them. The industry estimates there are roughly 400 active licenses in total across centers, manufacturers, facilitators, and laboratories. Ryan Reid, co-founder of the center Bendable Therapy, summarized his concern bluntly: “I don’t think the industry can survive this.” Daniel Huson, director of Rose City Laboratories, noted that the hike “removes any incentive to be a testing lab, because it’s already expensive as it is.” Heidi Pendergast, of the Healing Advocacy Fund, called the increase “unprecedented and disproportionate.” The official schedule sets the revised draft for September 1, a public comment period from September 1 to 21, and virtual hearings on September 15 and 16, prior to a final decision.

What this implies

It is important to note that this is still a proposal in the consultation phase, not an approved rule; the process itself allows for public input before any final decision is made. However, the Oregon case illustrates a fundamental tension in regulated models for legal access to psychedelic substances in the United States: because they are designed as self-funded programs without public budgets, their sustainability depends on having enough centers operating and paying fees. This creates a circular dependency that is difficult to resolve when the sector grows more slowly than anticipated. This is not a matter of legality or therapeutic efficacy, but of administrative architecture: how to fund a recognized right of access without turning it, through costs, into a privilege only available to those who can afford it. It is a debate that will likely repeat in other states and countries studying similar regulatory models.

Source

• The Astorian. “‘I don’t think the industry can survive this’: Oregon regulators propose steep psilocybin fee hikes”. The Astorian, July 6, 2026.

Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.